+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 6Years - 70Years
All Genders
Healthy Volunteers
ID05868733

Evaluating the Safety and Immune Response of rVSV-G-LASV-GPC Vaccine Compared to Placebo in Adults and Children in West Africa

Led by International AIDS Vaccine Initiative · Updated on 2026-10-23

530

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and immune response of the rVSV94G-LASV-GPC vaccine in adults and children living in West Africa. This Phase 2 clinical trial builds on earlier studies that showed the vaccine to be safe and able to protect animals against Lassa Fever. The study includes healthy adults, HIV-infected adults, adolescents, and children to better understand the vaccines effects across these groups and prepare for future effectiveness trials. Participants will receive one of three different doses of the rVSV94G-LASV-GPC vaccine or a placebo in a randomized, double-blinded manner. The vaccine is given as a single dose on Day 1. The study includes separate cohorts for healthy adults aged 18-70, HIV-infected adults aged 18-50, adolescents aged 12-17, and children aged 6-11. The study will observe vaccine safety and immune responses over various time points up to 7 months and beyond in some cases. During the study, participants will undergo medical exams, HIV testing, and monitoring for vaccine-related side effects. Researchers will measure antibody responses, vaccine presence in blood and body fluids, and immune system characteristics. Participants will be followed for safety and the duration of immune responses for up to 30 months in some cases. The study aims to provide detailed information on how well the vaccine is tolerated and how it stimulates the immune system in different age and health groups.

CONDITIONS

Brief Title

A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa

Research Team

G

Gaudensia Mutua

B

Babalwa Jongihlati

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here